News Headline Summary

EU says Johnson & Johnson (JNJ) and Novartis (NOVN VX) contracts delayed generic drugs

- Co.'s get EU antitrust objections.
- EU probings JNJ and NOVN VX contracts over Fentanyl painkiller.

Reaction details:

- Novartis shares are unmoved in reaction to the news; trades CHF 61.90 (-0.40%) last.

Print 10:46, 31 Jan 2013 - Global Equities - Source: Newswires